This large cap mutual fund gave 22% returns in one year; should you invest?
EDELWEISS LARGE CAP: The fund remains conscious of the benchmark while taking top-down sectoral calls and shuns cash calls. It usually runs positive active bets of 30-50%. The fund has exhibited a sharp outperformance over the past year.
By ET Bureau |
Getty Images
EDELWEISS LARGE CAP Fund: The fund prefers growing businesses that are available at reasonable valuations.
ET Wealth collaborates with Value Research to analyse top mutual funds. We examine the key fundamentals of the fund, its portfolio and performance to help you make an informed investment decision. EDELWEISS LARGE CAP BASIC FACTS DATE OF LAUNCH 20 MAY 2009 CATEGORY
EQUITY TYPE LARGE CAP AUM* Rs.621 crore BENCHMARK NIFTY 100 TOTAL RETURN INDEX
WHAT IT COSTS NAV** GROWTH OPTION Rs.69.81 IDCW** Rs.25.58 MINIMUM INVESTMENT
ADVERTISEMENT
Rs.100 MINIMUM SIP AMOUNT Rs.100
ADVERTISEMENT
EXPENSE RATIO# (%) 2.38 EXIT LOAD 1% for redemption within 90 days
*AS ON 30 NOV 2023 **AS ON 19 DEC 2023 #AS ON 30 NOV 2023
FUND MANAGER BHAVESH JAIN (LEFT)/BHARAT LAHOTI 2 YEARS, 1 MONTH /6 YEARS, 6 MONTHS
Recent portfolio changes New entrants Blue Jet Healthcare, JSW Infrastructure (Oct). Aditya Birla Capital, DLF, Flair Writing Industries, LTIMindtree, NMDC, Power Grid Corporation of India, Shree Cement, Tata Consumer Products, United Breweries (Nov). Complete exits Sai Silks (Kalamandir) (Oct). Blue Jet Healthcare, Crisil, GAIL (India), Gujarat Fluorochemicals, Hindustan Aeronautics, Hindustan Zinc, Jio Financial Services, PI Industries, SAMHI Hotels, Solar Industries India, Syngene International, Tata Elxsi, Thermax, Torrent Pharmaceuticals, Zydus Lifesciences (Nov).
Should You Buy? The fund prefers growing businesses that are available at reasonable valuations. It is more inclined towards stable and quality businesses and stays away from cyclical businesses. The fund remains conscious of the benchmark while taking top-down sectoral calls and shuns cash calls. It usually runs positive active bets of 30-50%. The fund has exhibited a sharp outperformance over the past year. Its direct plan, which shines over longer time frames, is a worthy pick even as the regular plan variant is weighed down by costs.
